Daiichi Sankyo
corporateWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Useful strategic partner target because the evidence shows Daiichi Sankyo partnering with an AI-enabled scientific platform company, indicating appetite for external discovery or translational collaborations relevant to OpenDrugs.